Neuropeptides and their receptors in CNS cancer imaging/theranostics: Review of recent advances and increased interest with emphasis on the somatostatin/bombesin/substance P peptide receptor families. (PubMed, J Neuroendocrinol) - Oct 10, 2026 - P3 | "We also discuss the specific problems that the CNS presents in applying this approach to CNS tumors because of the blood-brain barrier in addition to the progress made. Clinical Trial Registry: NCT01578239 (NETTER-1)(NET), NCT03972488 (NETTER-2)(NET): VISION Trial (NCT03511664)[Lu-177-PSMA-617] (Pluvicto) in advanced prostate cancer."
Journal • Review • Brain Cancer • CNS Tumor • Genito-urinary Cancer • Genitourinary Neuroendocrine Tumor • Glioblastoma • Glioma • Medulloblastoma • Meningioma • Neuroendocrine Tumor • Oncology • Prostate Cancer • Solid Tumor • GRP-10
|
|
Irene Ramos-Alvarez; Robert T Jensen; Terry W Moody
|